Pharmacologic evidence suggests that activation of A 2B adenosine receptors results in proinflammatory effects relevant to the progression of asthma, a chronic lung disease associated with elevated interstitial adenosine concentrations in the lung. This concept has been challenged by the finding that genetic removal of A 2B receptors leads to exaggerated responses in models of acute inflammation. Therefore, the goal of our study was to determine the effects of A 2B receptor gene ablation in the context of ovalbumin-induced chronic pulmonary inflammation. We found that repetitive airway allergen challenge induced a significant increase in adenosine levels in fluid recovered by bronchoalveolar lavage. Genetic ablation of A 2B receptors significantly attenuated allergen-induced chronic pulmonary inflammation, as evidenced by a reduction in the number of bronchoalveolar lavage eosinophils and in peribronchial eosinophilic infiltration. The most striking difference in the pulmonary inflammation induced in A 2B receptor knockout (A 2B KO) and wildtype mice was the lack of allergen-induced IL-4 release in the airways of A 2B KO animals, in line with a significant reduction in IL-4 protein and mRNA levels in lung tissue. In addition, attenuation of allergeninduced transforming growth factor-b release in airways of A 2B KO mice correlated with reduced airway smooth muscle and goblet cell hyperplasia/hypertrophy. In conclusion, genetic removal of A 2B adenosine receptors in mice leads to inhibition of allergen-induced chronic pulmonary inflammation and airway remodeling. These findings are in agreement with previous pharmacologic studies suggesting a deleterious role for A 2B receptor signaling in chronic lung inflammation.Keywords: adenosine; asthma; pulmonary inflammation; IL-4; transforming growth factor-bInterstitial adenosine concentrations are increased during inflammation as a result of cell stress, injury, and tissue hypoxia (1, 2). Extracellular adenosine functions as a signaling molecule by engaging cell surface G protein-coupled receptors of the P1 purinergic family comprising A 1 , A 2A , A 2B , and A 3 adenosine receptor subtypes (2). There is growing evidence that adenosine plays an important role in the regulation of inflammation. Inhibition of acute inflammation is a well-recognized effect of adenosine, which has been attributed primarily to stimulation of A 2A adenosine receptors on immune and endothelial cells (3). Recent evidence, however, suggests that adenosine can promote chronic inflammation by up-regulating proinflammatory cytokines. Studies in adenosine deaminase (ADA)-deficient mice, characterized by elevated lung tissue levels of adenosine, demonstrated an association between adenosine and an inflammatory phenotype (4, 5). These mice exhibit a pulmonary phenotype with features of inflammation, mucous metaplasia, increased IgE synthesis, and elevated levels of proinflammatory cytokines, all of which could be reversed by lowering adenosine levels with exogenous ADA (4). Correlation between lung ad...